WHO Prequalifies First Generic Hepatitis C Drug And First HIV Self-Test
— 2017-07-21In the days before this month’s AIDS conference being held in Paris, the World Health Organization has
Continue Reading ...Home / Health & IP
-
-
Temporary Compulsory License For Antiretroviral Drug Upheld By German Court
— 2017-07-17MUNICH — The German Federal Supreme Court in a decision drawing significant attention on 11 July upheld
Continue Reading ... -
Event Looks At UN High-Level Panel On Medicines Access, SDGs And Policy Coherence
— 2017-07-14An event on 17 July at the United Nations in New York will address the “UN Secretary General’s High-Level
Continue Reading ... -
3P Project Enables Radical Change In R&D For TB Treatment
— 2017-07-14A new project that stimulates the development of affordable and effective drug regimens to treat tuberculosis
Continue Reading ... -
Access To Medicines For All By 2030: New WHO Strategic Framework Sets Vision
— 2017-07-13Access to affordable and quality medicines for all is one of the major commitments of the World Health
Continue Reading ... -
WIPO Patent Law Committee Agrees On Future Work: Exceptions, Quality, Health, Confidentiality, Tech Transfer
— 2017-07-07General satisfaction was expressed today at the World Intellectual Property Organization as members of
Continue Reading ... -
WIPO Patent Law Committee Looks At Health, Quality
— 2017-07-06Discussions carried out at the World Intellectual Property Organization patent law committee this week
Continue Reading ... -
Medicines Patent Pool Nets WHO’s Kieny As New Chair
— 2017-07-03Marie-Paule Kieny, fresh out of the World Health Organization, where she held the position of assistant
Continue Reading ... -
Novartis Loses Claim On Extension Of Data Exclusivity
— 2017-06-28In a decision today, the European Court of Justice in Luxembourg put an end to a complaint by Novartis
Continue Reading ... -
UN Human Rights Council Adopts Access To Medicines Resolution
— 2017-06-24The United Nations Human Rights Council today adopted a resolution on the right to health in relation
Continue Reading ... -
TRIPS Council Members: Defining IP Rights And The Public Interest
— 2017-06-15“Political and economic pressure placed on governments to forgo the use of TRIPS flexibilities violates
Continue Reading ... -
US Supreme Court Adopts International Exhaustion Of Patents (Part II): Addressing the New Competitive Landscape
— 2017-06-08The US Supreme Court has created a new competitive landscape with its decision adopting international
Continue Reading ... -
IP And The Public Interest Premieres At TRIPS Council Next Week
— 2017-06-07It has become a tradition at the World Trade Organization committee on intellectual property to have
Continue Reading ... -
New WHO Essential Medicines List: Antibiotics, Hepatitis C, Leukaemia, TB
— 2017-06-07The World Health Organization’s new list of essential medicines, those which should be available to everyone,
Continue Reading ... -
REGISTER NOW! The Global Debate On Intellectual Property, Trade And Development: Past, Present and Future
— 2017-06-06REGISTER NOW The University of Minnesota Law School, The Faculty of Law,
Continue Reading ... -
A Summary Of Key IP-Related Actions Taken By The 70th World Health Assembly
— 2017-05-31After what was described as the biggest World Health Assembly ever, with the highest number of agenda
Continue Reading ... -
Resolution On Cancer Hailed By WHO Members, Easily Adopted In Committee
— 2017-05-31It is not a mystery, cancer has been spreading for decades, in particular in low and-middle income countries,
Continue Reading ... -
US Supreme Court Adopts International Exhaustion For Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices
— 2017-05-31The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of
Continue Reading ... -
WHA Bans IP Reference In Substandard And Falsified Medicines
— 2017-05-31The “delicious acronym SSFFC” – as described by Marie-Paule Kieny, assistant director-general
Continue Reading ... -
Cancer Drugs: Innovation ‘Blackmail’ Leads To Unaffordable Prices, Delinkage Needed, Speakers Say
— 2017-05-30What if you get an aggressive form of breast cancer, and the treatment exists but it is too expensive
Continue Reading ...
-
カテゴリー